The Epidemiology of Molecular Alterations in Mesothelioma

间皮瘤分子改变的流行病学

基本信息

  • 批准号:
    7790575
  • 负责人:
  • 金额:
    $ 49.36万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2008
  • 资助国家:
    美国
  • 起止时间:
    2008-05-17 至 2013-03-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Exposure to asbestos has long been associated with pleural mesothelioma. The mode of action of asbestos in inducing mesothelioma, however, remains to be completely described, and relatively little is known about the association of epigenetic inactivation of tumor suppressor genes with carcinogenic exposures. Asbestos is not a direct-acting mutagen, but is carcinogenic; as such, it is also known to persist in the lungs of exposed individuals. Our preliminary data has demonstrated that asbestos fiber burden is significantly associated with the number of tumor suppressor genes inactivated by epigenetic silencing and DNA methylation. We propose to expand this research by taking advantage of the newly developed International Mesothelioma Program (IMP) at the Brigham and Women's Hospital (BWH), where novel surgical treatment protocols have made possible for the first time investigation of tumor tissue from individuals with mesothelioma. We propose to test hypotheses positing that epigenetic inactivation of tumor suppressor genes, measured by assessing the DNA methylation profile, is associated with asbestos fiber type and burden. Further, we will test the hypothesis that the SV40 virus is involved in mesothelioma using a novel artifact resistant approach, and investigate the role of miRNAs in mesothelioma, asking if this might be a novel biomarker for this disease. Finally, we will test the hypothesis that survival in mesothelioma is associated with the individual molecular profile of the tumor. Our data will also be pooled with the expression profile data being generated at the BWH as part of the IMP, giving rise to a very rich repository of global genomic data for the exploratory analysis of the systems biology of malignant mesothelioma. In sum, we propose to continue to enroll and study patients referred to the BWH for new surgical treatments of this often fatal cancer. We will study the molecular character of their tumors, proposing that the character of the lesions in the tumor is associated with the nature of their asbestos exposure and well as with their response to treatment. Mesothelioma is a most often fatal cancer caused by asbestos exposure. We propose to study novel mechanisms of asbestos action in the body (including the inactivation and silencing of genes by induction of altered chromosome conformations), associating these with quantitative measures of asbestos exposure. This may help to explain, for example, why even small exposures ("doses") of asbestos pose a fatal cancer risk.
描述(由申请人提供):长期以来,石棉暴露与胸膜间皮瘤有关。然而,石棉在诱导间皮瘤中的作用模式仍有待完全描述,并且对肿瘤抑制基因的表观遗传失活与致癌暴露之间的关系知之甚少。石棉不是直接作用的诱变剂,但具有致癌性;因此,人们也知道它会在接触者的肺部持续存在。我们的初步数据表明,石棉纤维负荷与表观遗传沉默和DNA甲基化使肿瘤抑制基因失活的数量显著相关。我们建议利用布里格姆妇女医院(BWH)新开发的国际间皮瘤项目(IMP)来扩大这项研究,在该项目中,新的手术治疗方案首次使间皮瘤患者肿瘤组织的研究成为可能。我们建议验证通过评估DNA甲基化谱测量的肿瘤抑制基因的表观遗传失活与石棉纤维类型和负担相关的假设。此外,我们将使用一种新的伪迹抗性方法来验证SV40病毒参与间皮瘤的假设,并研究mirna在间皮瘤中的作用,询问这是否可能是这种疾病的一种新的生物标志物。最后,我们将验证间皮瘤患者的生存与肿瘤的个体分子特征相关的假设。我们的数据还将与BWH生成的表达谱数据合并,作为IMP的一部分,为恶性间皮瘤系统生物学的探索性分析提供非常丰富的全球基因组数据存储库。总之,我们建议继续招募和研究转介到BWH的患者,以寻求新的手术治疗这种通常致命的癌症。我们将研究他们肿瘤的分子特征,提出肿瘤中病变的特征与他们接触石棉的性质以及他们对治疗的反应有关。间皮瘤是由接触石棉引起的最常见的致命癌症。我们建议研究石棉在体内作用的新机制(包括通过诱导染色体构象改变而使基因失活和沉默),并将这些机制与石棉暴露的定量测量联系起来。这可能有助于解释,例如,为什么即使很小的石棉暴露(“剂量”)也会造成致命的癌症风险。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Karl Timothy Kelsey其他文献

Karl Timothy Kelsey的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Karl Timothy Kelsey', 18)}}的其他基金

The Epidemiology of Molecular Alterations in Mesothelioma
间皮瘤分子改变的流行病学
  • 批准号:
    8037040
  • 财政年份:
    2008
  • 资助金额:
    $ 49.36万
  • 项目类别:
The Epidemiology of Molecular Alterations in Mesothelioma
间皮瘤分子改变的流行病学
  • 批准号:
    7625241
  • 财政年份:
    2008
  • 资助金额:
    $ 49.36万
  • 项目类别:
The Epidemiology of Molecular Alterations in Mesothelioma
间皮瘤分子改变的流行病学
  • 批准号:
    7379863
  • 财政年份:
    2008
  • 资助金额:
    $ 49.36万
  • 项目类别:
The Epidemiology of Molecular Alterations in Mesothelioma
间皮瘤分子改变的流行病学
  • 批准号:
    8291401
  • 财政年份:
    2008
  • 资助金额:
    $ 49.36万
  • 项目类别:
The Molecular Epidemiology of Bladder Cancer
膀胱癌的分子流行病学
  • 批准号:
    7629012
  • 财政年份:
    2007
  • 资助金额:
    $ 49.36万
  • 项目类别:
The Molecular Epidemiology of Bladder Cancer
膀胱癌的分子流行病学
  • 批准号:
    7934210
  • 财政年份:
    2007
  • 资助金额:
    $ 49.36万
  • 项目类别:
The Molecular Epidemiology of Bladder Cancer
膀胱癌的分子流行病学
  • 批准号:
    7774344
  • 财政年份:
    2007
  • 资助金额:
    $ 49.36万
  • 项目类别:
The Molecular Epidemiology of Bladder Cancer
膀胱癌的分子流行病学
  • 批准号:
    7541681
  • 财政年份:
    2007
  • 资助金额:
    $ 49.36万
  • 项目类别:
The Molecular Epidemiology of Bladder Cancer
膀胱癌的分子流行病学
  • 批准号:
    7414757
  • 财政年份:
    2007
  • 资助金额:
    $ 49.36万
  • 项目类别:
Patterns of Somatic Gene Alterations in Oral Cancer
口腔癌体细胞基因改变模式
  • 批准号:
    7023849
  • 财政年份:
    2004
  • 资助金额:
    $ 49.36万
  • 项目类别:

相似海外基金

Interrogating the role of mutant KRAS allelic imbalance and co-mutated genes in targeted therapy response of NSCLC
探究突变 KRAS 等位基因失衡和共突变基因在 NSCLC 靶向治疗反应中的作用
  • 批准号:
    10672963
  • 财政年份:
    2021
  • 资助金额:
    $ 49.36万
  • 项目类别:
Interrogating the role of mutant KRAS allelic imbalance and co-mutated genes in targeted therapy response of NSCLC
探究突变 KRAS 等位基因失衡和共突变基因在 NSCLC 靶向治疗反应中的作用
  • 批准号:
    10474286
  • 财政年份:
    2021
  • 资助金额:
    $ 49.36万
  • 项目类别:
Allelic Imbalance in Regulation of ANRIL through Chromatin Interaction at 9p21 Endometriosis Risk Locus
通过 9p21 子宫内膜异位症风险位点染色质相互作用调节 ANRIL 的等位基因不平衡
  • 批准号:
    15H02373
  • 财政年份:
    2015
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Grant-in-Aid for Scientific Research (A)
Genomic constrain and plasticity of vocal phenotypes by regulation of allelic imbalance
通过等位基因不平衡的调节来限制声音表型的基因组和可塑性
  • 批准号:
    25640097
  • 财政年份:
    2013
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
Role of maternal diet and allelic imbalance in behavior.
母亲饮食和等位基因失衡在行为中的作用。
  • 批准号:
    8654359
  • 财政年份:
    2013
  • 资助金额:
    $ 49.36万
  • 项目类别:
Role of maternal diet and allelic imbalance in behavior.
母亲饮食和等位基因失衡在行为中的作用。
  • 批准号:
    8829921
  • 财政年份:
    2013
  • 资助金额:
    $ 49.36万
  • 项目类别:
Role of maternal diet and allelic imbalance in behavior.
母亲饮食和等位基因失衡在行为中的作用。
  • 批准号:
    8482731
  • 财政年份:
    2013
  • 资助金额:
    $ 49.36万
  • 项目类别:
Allelic imbalance mapping to uncover cSCC susceptibility alleles
等位基因不平衡图谱揭示 cSCC 易感性等位基因
  • 批准号:
    8575837
  • 财政年份:
    2013
  • 资助金额:
    $ 49.36万
  • 项目类别:
Integrated Genetic Analysis of Allelic Imbalance and FGFR3 Mutation by SNP-based Pyrosequencing in Urothelial Cancer
基于 SNP 的焦磷酸测序对尿路上皮癌等位基因失衡和 FGFR3 突变进行综合遗传分析
  • 批准号:
    24890206
  • 财政年份:
    2012
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Genetics and Epigenetics of Serotonin System in Suicidal Behaviour: CpG SNP Mapping, Methylation and Allelic Imbalance Analysis
自杀行为中血清素系统的遗传学和表观遗传学:CpG SNP 定位、甲基化和等位基因不平衡分析
  • 批准号:
    240155
  • 财政年份:
    2011
  • 资助金额:
    $ 49.36万
  • 项目类别:
    Operating Grants
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了